MAIA Biotechnology, Inc.

For the period ended May 24, 2024. Filed Apr 16, 2024.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

May 24, 2024 · Filed Apr 16, 2024

Use the contents to explore the available documents and sections.

MAIA$1.06+1.9%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

AVAILABILITY OF ANNUAL REPORT AND PROXY STATEMENT

If you would like to receive a copy of our Annual Report on Form 10-K for the Year Ended December 31, 2023 and/or this proxy statement, please contact us at: MAIA Biotechnology, Inc., 444 West Lake Street, Suite 1700, Chicago, Illinois 60606, attn.: Corporate Secretary or by telephone at (312) 416-8592, and we will send a copy to you without charge. Our Annual Report on Form 10-K for the Year Ended December 31, 2023 and this proxy statement can also found on our website, https://ir.maiabiotech.com/sec-filings/all-sec-filings.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.